ARCHIVES

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

NCI To Support 39 Summer Students With Gift Money

February 8, 1985

Doroshow: NCI Leaves It Up to Groups To Make Their Own Merger Deals

February 11, 2011

Varmus, Duke Ask IOM To Investigate Potti’s Scientific Work, Clinical Trials

July 30, 2010

New Source of Research Funds? As Clinton Derails Tobacco Deal, Prospects May Brighten for Tougher Measures In ‘98

September 19, 1997

Clinical Research Needs Payment Mechanism, Kerrey

February 4, 1994

Protein Patterns May Identify Ovarian Cancer Earlier

March 29, 2002